Lattice Therapeutics, Inc.
Biotechnology company · Washington, District of Columbia, United States
Lattice Therapeutics, Inc. is a biotechnology company headquartered in Washington, District of Columbia, United States. Its earliest recorded incorporation is in 2020. It has reported private securities offerings to the US SEC, most recently $300,000 sold in a notice filed in 2022.
Lattice Therapeutics at a glance
What does Lattice Therapeutics do?
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $300,000 sold (2022).
Frequently asked questions about Lattice Therapeutics
Where is Lattice Therapeutics headquartered?
Lattice Therapeutics, Inc. is headquartered in Washington, District of Columbia, United States.
What does Lattice Therapeutics do?
Lattice Therapeutics, Inc. is a biotechnology company.
When was Lattice Therapeutics founded?
The earliest incorporation on record for Lattice Therapeutics, Inc. is in 2020, according to public company registers.
Similar companies
- Vitakey Inc.Washington, District of Columbia, United States
- Floreo, Inc.Washington, District of Columbia, United States
- OncovirWashington, District of Columbia, United States
- Nanochon, Inc.Washington, District of Columbia, United States
- Media Rez LLCWashington, District of Columbia, United States
- Amelia Technologies LLCWashington, District of Columbia, United States
- Cyrano Therapeutics, Inc.Washington, District of Columbia, United States
- Neuroene Therapeutics IncWashington, District of Columbia, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences